Nanotech Investing Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Nanotech Investing Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Nanotech Investing Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Nanotech Investing Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
Nanotech Investing Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
Nanotech Investing Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Nanotech Investing Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Nanotech Investing Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Nanotech Investing Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
